Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Mungara has over 25+ years of experience in the supply chain domain
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
More than 10,000 scientific publications containing EUDRAGIT
Sen spent a decade with Biocon and held various key roles,
The drug will target specific genetic mutations prevalent in certain types of cancers
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Subscribe To Our Newsletter & Stay Updated